Skip to main content
Top
Published in: Journal of General Internal Medicine 2/2012

01-02-2012 | Perspectives

Evidence, Values, Guidelines and Rational Decision-making

Author: Bruce Barrett, MD PhD

Published in: Journal of General Internal Medicine | Issue 2/2012

Login to get access

Abstract

Medical decision-making involves choices, which can lead to benefits or to harms. Most benefits and harms may or may not occur, and can be minor or major when they do. Medical research, especially randomized controlled trials, provides estimates of chance of occurrence and magnitude of event. Because there is no universally accepted method for weighing harms against benefits, and because the ethical principle of autonomy mandates informed choice by patient, medical decision-making is inherently an individualized process. It follows that the practice of aiming for universal implementation of standardized guidelines is irrational and unethical. Irrational because the possibility of benefits is implicitly valued more than the possibility of comparable harms, and unethical because guidelines remove decision making from the patient and give it instead to a physician, committee or health care system. This essay considers the cases of cancer screening and diabetes management, where guidelines often advocate universal implementation, without regard to informed choice and individual decision-making.
Literature
1.
go back to reference Guyatt GH, Rennie D. Users' Guides to the Literature: A Manual for Evidence-Based Clinical Practice. Chicago: AMA Press; 2002. Guyatt GH, Rennie D. Users' Guides to the Literature: A Manual for Evidence-Based Clinical Practice. Chicago: AMA Press; 2002.
2.
go back to reference Beauchamp T, Childress J. Principles of Biomedical Ethics. New York: Oxford University Press; 2001. Beauchamp T, Childress J. Principles of Biomedical Ethics. New York: Oxford University Press; 2001.
4.
go back to reference Tarasenko YN, Wackerbarth SB, Love MM, Joyce JM. Haist SA. Colorectal cancer screening: Patients' and physicians' perspectives on decision-making factors. J. Cancer Educ; 2010. Tarasenko YN, Wackerbarth SB, Love MM, Joyce JM. Haist SA. Colorectal cancer screening: Patients' and physicians' perspectives on decision-making factors. J. Cancer Educ; 2010.
5.
go back to reference Woloshin S, Schwartz LM. The benefits and harms of mammography screening: understanding the trade-offs. JAMA. 2010;303:164–5.PubMedCrossRef Woloshin S, Schwartz LM. The benefits and harms of mammography screening: understanding the trade-offs. JAMA. 2010;303:164–5.PubMedCrossRef
6.
go back to reference Gotzsche PC. Increased incidence of invasive breast cancer after the introduction of service screening with mammography in Sweden. Int. J. Cancer. 2006;118:2648.PubMedCrossRef Gotzsche PC. Increased incidence of invasive breast cancer after the introduction of service screening with mammography in Sweden. Int. J. Cancer. 2006;118:2648.PubMedCrossRef
7.
go back to reference Kerlikowske K. A call for evidence of benefits outweighing harms before implementing new technologies: comment on "Diffusion of computer-aided mammography after mandated Medicare coverage". Arch. Intern. Med. 2010;170:990–1.PubMedCrossRef Kerlikowske K. A call for evidence of benefits outweighing harms before implementing new technologies: comment on "Diffusion of computer-aided mammography after mandated Medicare coverage". Arch. Intern. Med. 2010;170:990–1.PubMedCrossRef
9.
go back to reference Croswell JM, Kramer BS, Kreimer AR, Prorok PC, Xu JL, Baker SG, et al. Cumulative incidence of false-positive results in repeated, multimodal cancer screening. Ann. Fam. Med. 2009;7:212–22.PubMedCrossRef Croswell JM, Kramer BS, Kreimer AR, Prorok PC, Xu JL, Baker SG, et al. Cumulative incidence of false-positive results in repeated, multimodal cancer screening. Ann. Fam. Med. 2009;7:212–22.PubMedCrossRef
10.
go back to reference Ewart RM. The case against aggressive treatment of type 2 diabetes: critique of the UK prospective diabetes study. BMJ. 2001;323:854–8.PubMedCrossRef Ewart RM. The case against aggressive treatment of type 2 diabetes: critique of the UK prospective diabetes study. BMJ. 2001;323:854–8.PubMedCrossRef
11.
go back to reference ACCORD authors. Effects of intensive glucose lowering in Type 2 diabetes. N.Engl.J.Med. 2008. ACCORD authors. Effects of intensive glucose lowering in Type 2 diabetes. N.Engl.J.Med. 2008.
12.
go back to reference Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N.Engl.J.Med. 2008;358:2560–72.PubMedCrossRef Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N.Engl.J.Med. 2008;358:2560–72.PubMedCrossRef
13.
go back to reference Dluhy RG, McMahon GT. Intensive Glycemic Control in the ACCORD and ADVANCE Trials. N.Engl.J.Med. 2008. Dluhy RG, McMahon GT. Intensive Glycemic Control in the ACCORD and ADVANCE Trials. N.Engl.J.Med. 2008.
14.
go back to reference Brody H, Light DW. The inverse benefit law: how drug marketing undermines patient safety and public health. Am. J. Public Health. 2011;101:399–404.PubMedCrossRef Brody H, Light DW. The inverse benefit law: how drug marketing undermines patient safety and public health. Am. J. Public Health. 2011;101:399–404.PubMedCrossRef
15.
go back to reference Barry MJ. Health decision aids to facilitate shared decision making in office practice. Ann Intern Med. 2002;136:127–35.PubMed Barry MJ. Health decision aids to facilitate shared decision making in office practice. Ann Intern Med. 2002;136:127–35.PubMed
16.
go back to reference Schroy PC III. Emmons K, Peters E, Glick JT, Robinson PA, Lydotes MA et al. The impact of a novel computer-based decision aid on shared decision making for colorectal cancer screening: A randomized trial. Med. Decis. Making; 2010. Schroy PC III. Emmons K, Peters E, Glick JT, Robinson PA, Lydotes MA et al. The impact of a novel computer-based decision aid on shared decision making for colorectal cancer screening: A randomized trial. Med. Decis. Making; 2010.
17.
go back to reference Nelson W, Reyna VF, Fagerlin A, Lipkus I, Peters E. Clinical implications of numeracy: theory and practice. Ann. Behav. Med. 2008;35:261–74.PubMedCrossRef Nelson W, Reyna VF, Fagerlin A, Lipkus I, Peters E. Clinical implications of numeracy: theory and practice. Ann. Behav. Med. 2008;35:261–74.PubMedCrossRef
18.
go back to reference Galesic M, Gigerenzer G, Straubinger N. Natural frequencies help older adults and people with low numeracy to evaluate medical screening tests. Med Decis Making. 2009;29:368s–371.CrossRef Galesic M, Gigerenzer G, Straubinger N. Natural frequencies help older adults and people with low numeracy to evaluate medical screening tests. Med Decis Making. 2009;29:368s–371.CrossRef
19.
go back to reference Barrett B, McKenna P. Communicating benefits and risks of screening for prostate, colon, and breast cancer. Fam. Med. 2011;43:248–53.PubMed Barrett B, McKenna P. Communicating benefits and risks of screening for prostate, colon, and breast cancer. Fam. Med. 2011;43:248–53.PubMed
20.
go back to reference Charles C, Gafni A, Whelan T. Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc. Sci. Med. 1999;49:651–61.PubMedCrossRef Charles C, Gafni A, Whelan T. Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc. Sci. Med. 1999;49:651–61.PubMedCrossRef
21.
go back to reference Sandman L, Munthe C. Shared decision-making and patient autonomy. Theor. Med. Bioeth. 2009;30:289–310.PubMedCrossRef Sandman L, Munthe C. Shared decision-making and patient autonomy. Theor. Med. Bioeth. 2009;30:289–310.PubMedCrossRef
22.
go back to reference Stacey D, Legare F, Pouliot S, Kryworuchko J. Dunn S. Shared decision making models to inform an interprofessional perspective on decision making: A theory analysis. Patient Educ. Couns; 2009. Stacey D, Legare F, Pouliot S, Kryworuchko J. Dunn S. Shared decision making models to inform an interprofessional perspective on decision making: A theory analysis. Patient Educ. Couns; 2009.
23.
go back to reference Cochrane's legacy. Lancet 1992;340:1131–2. Cochrane's legacy. Lancet 1992;340:1131–2.
Metadata
Title
Evidence, Values, Guidelines and Rational Decision-making
Author
Bruce Barrett, MD PhD
Publication date
01-02-2012
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 2/2012
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-011-1903-6

Other articles of this Issue 2/2012

Journal of General Internal Medicine 2/2012 Go to the issue

Healing Arts: Materia Medica

The Anatomy Professor

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine